Trial Profile
Follow-Up Study in Patients with Acromegaly Previously Participating in Chiasma Study CH-ACM-01
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Dec 2022
Price :
$35
*
At a glance
- Drugs Octreotide (Primary)
- Indications Acromegaly
- Focus Registrational; Therapeutic Use
- Sponsors Chiasma
- 09 Mar 2016 Status changed from recruiting to completed, according to European Clinical Trials Database record.
- 23 Jun 2015 New trial record